BIIE-0246

BIIE-0246 is a selective neuropeptide Y receptor antagonist that has been studied for its potential effects on anxiety, depression, and feeding behavior. It specifically targets the Y2 receptor subtype, which is one of the several receptor subtypes for the neuropeptide Y (NPY) family.

Chemical Properties

BIIE-0246 is a synthetic compound with a complex chemical structure designed to selectively inhibit the Y2 receptor. The chemical name and molecular formula of BIIE-0246 are as follows:

• Chemical Name:
• Molecular Formula:

Mechanism of Action

BIIE-0246 functions by binding to the Y2 receptor, thereby blocking the action of neuropeptide Y. The Y2 receptor is primarily involved in the regulation of neurotransmitter release, particularly in the central nervous system. By inhibiting this receptor, BIIE-0246 can modulate various physiological processes, including anxiety, depression, and appetite.

Pharmacological Effects

Studies have shown that BIIE-0246 can produce anxiolytic and antidepressant-like effects in animal models. It has also been observed to influence feeding behavior, potentially reducing food intake by modulating the signaling pathways associated with hunger and satiety.

Anxiety and Depression

Research indicates that BIIE-0246 may have therapeutic potential in the treatment of anxiety disorders and depression. By blocking the Y2 receptor, it can alter the release of neurotransmitters such as serotonin and norepinephrine, which are critical in mood regulation.

Feeding Behavior

BIIE-0246 has been studied for its effects on feeding behavior. The Y2 receptor plays a significant role in the regulation of appetite, and antagonism of this receptor by BIIE-0246 can lead to reduced food intake, making it a potential candidate for the treatment of obesity and related metabolic disorders.

Research and Development

BIIE-0246 is primarily used in preclinical research to understand the role of the Y2 receptor in various physiological and pathological processes. Its selective antagonism makes it a valuable tool for dissecting the specific functions of the Y2 receptor in the central nervous system and peripheral tissues.

Potential Therapeutic Applications

While BIIE-0246 is not currently approved for clinical use, its pharmacological profile suggests potential applications in the treatment of anxiety disorders, depression, and obesity. Further research is needed to fully understand its therapeutic potential and safety profile.

See Also

• Neuropeptide Y
• Y2 receptor
• Anxiety
• Depression
• Feeding behavior
• Obesity